XML 36 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders’ Equity and Equity Incentive Plans (Tables)
9 Months Ended
Oct. 31, 2020
Stockholders' Equity Note [Abstract]  
Summary of Stock Option Activity Under Equity Incentive Plan
A summary of stock option activity under our equity incentive plan and related information is as follows:
 Stock Options
Outstanding
Stock
Options
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
(in thousands, except share, life, and per share data)
Balance as of January 31, 202016,833,009 $5.73 7.6$1,191,881 
Granted— $— 
Exercised(6,164,676)$3.87 
Canceled/forfeited/expired(190,164)$6.14 
Balance as of October 31, 202010,478,169 $6.81 7.1$4,757,980 
Vested and exercisable as of October 31, 20204,811,474 $3.49 6.5$2,200,842 
Summary of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan A summary of RSU activity under our equity incentive plan and related information is as follows:
RSUs
Unvested
RSUs
Weighted-
Average
Grant Date Fair Value Per Share
Unvested as of January 31, 20201,964,668 $79.11 
Granted3,091,931 $228.82 
Vested(435,302)$86.39 
Canceled/forfeited(155,751)$165.09 
Unvested as of October 31, 20204,465,546 $179.06 
Summary of Stock-based Compensation Expense by Line Item
The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows:
Three Months Ended October 31,Nine Months Ended October 31,
2020201920202019
(in thousands)
Cost of revenue$11,287 $2,369 $22,263 $5,101 
Research and development16,035 3,642 31,269 7,316 
Sales and marketing46,716 12,488 96,237 25,554 
General and administrative19,887 3,296 29,788 8,561 
Total stock-based compensation expense$93,925 $21,795 $179,557 $46,532